[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2093286T3 - Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. - Google Patents

Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.

Info

Publication number
ES2093286T3
ES2093286T3 ES93100890T ES93100890T ES2093286T3 ES 2093286 T3 ES2093286 T3 ES 2093286T3 ES 93100890 T ES93100890 T ES 93100890T ES 93100890 T ES93100890 T ES 93100890T ES 2093286 T3 ES2093286 T3 ES 2093286T3
Authority
ES
Spain
Prior art keywords
benzimidazoles
compounds
procedure
preparation
medicines containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93100890T
Other languages
English (en)
Inventor
Norbert Dr Dipl-Chem Hauel
Berthold Dr Dipl-Chem Narr
Uwe Dr Dipl-Chem Ries
Meel Jacques Dr Van
Wolfgang Dr Dipl-Biolog Wienen
Michael Dr Dipl-Chem Entzeroth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4201554A external-priority patent/DE4201554A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of ES2093286T3 publication Critical patent/ES2093286T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Toys (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Instructional Devices (AREA)

Abstract

LA INVENCION CONCIERNE A BENCIMIDAZOLES, DE FORMULA GENERAL, EN LA QUE, R1 A R4 ESTAN DEFINIDOS COMO EN LA SOLICITUD 1, Y SUS SALES, QUE PRESENTAN PROPIEDADES VALIOSAS. LOS NUEVOS COMPUESTOS REPRESENTAN ESPECIALMENTE ANTAGONISTAS A LA ANGIOTENSINA.
ES93100890T 1992-01-22 1993-01-21 Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. Expired - Lifetime ES2093286T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4201554A DE4201554A1 (de) 1992-01-22 1992-01-22 Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4219782A DE4219782A1 (de) 1992-01-22 1992-06-17 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4225756A DE4225756A1 (de) 1992-01-22 1992-08-04 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES2093286T3 true ES2093286T3 (es) 1996-12-16

Family

ID=27203316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93100890T Expired - Lifetime ES2093286T3 (es) 1992-01-22 1993-01-21 Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.

Country Status (18)

Country Link
EP (1) EP0552765B1 (es)
JP (1) JPH05279341A (es)
AT (1) ATE141270T1 (es)
AU (1) AU660209B2 (es)
CA (1) CA2087800A1 (es)
CZ (1) CZ394492A3 (es)
DE (2) DE4225756A1 (es)
DK (1) DK0552765T3 (es)
ES (1) ES2093286T3 (es)
FI (1) FI930236A (es)
GR (1) GR3021303T3 (es)
HU (1) HU217816B (es)
IL (1) IL104485A (es)
MX (1) MX9300306A (es)
NO (1) NO303689B1 (es)
NZ (1) NZ245741A (es)
PL (1) PL172782B1 (es)
SK (1) SK279409B6 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EP2377521A1 (en) 2010-03-26 2011-10-19 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Pharmaceutical formulations of telmisartan and diuretic combination
CN105492439B (zh) 2013-06-21 2019-11-22 齐尼思表观遗传学有限公司 作为溴结构域抑制剂的取代的双环化合物
KR102307566B1 (ko) 2013-06-21 2021-10-05 제니쓰 에피제네틱스 리미티드 신규한 바이사이클릭 브로모도메인 억제제
EP3027604B1 (en) 2013-07-31 2019-02-20 Zenith Epigenetics Ltd. Novel quinazolinones as bromodomain inhibitors
US10710992B2 (en) 2014-12-01 2020-07-14 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
WO2016092375A1 (en) 2014-12-11 2016-06-16 Zenith Epigenetics Corp. Substituted heterocycles as bromodomain inhibitors
EP3233846A4 (en) 2014-12-17 2018-07-18 Zenith Epigenetics Ltd. Inhibitors of bromodomains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo

Also Published As

Publication number Publication date
SK394492A3 (en) 1998-11-04
PL297472A1 (en) 1994-01-24
DE4225756A1 (de) 1994-03-10
DE59303388D1 (de) 1996-09-19
NO303689B1 (no) 1998-08-17
AU3196293A (en) 1993-07-29
CZ394492A3 (en) 1993-11-17
NO930205L (no) 1993-07-23
IL104485A (en) 1999-10-28
SK279409B6 (sk) 1998-11-04
FI930236A0 (fi) 1993-01-21
HU9300168D0 (en) 1993-04-28
IL104485A0 (en) 1993-05-13
NO930205D0 (no) 1993-01-21
HU217816B (hu) 2000-04-28
MX9300306A (es) 1993-07-01
JPH05279341A (ja) 1993-10-26
NZ245741A (en) 1995-07-26
AU660209B2 (en) 1995-06-15
GR3021303T3 (en) 1997-01-31
EP0552765B1 (de) 1996-08-14
HUT63626A (en) 1993-09-28
PL172782B1 (pl) 1997-11-28
DK0552765T3 (da) 1997-01-13
EP0552765A1 (de) 1993-07-28
FI930236A (fi) 1993-07-23
ATE141270T1 (de) 1996-08-15
CA2087800A1 (en) 1993-07-23

Similar Documents

Publication Publication Date Title
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
ES2088915T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
DK0530505T3 (da) Hydantoinderivater
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
SE8406585L (sv) Bensoesyraderivat
ES2194842T3 (es) Derivados de 2,4-dioxo-imidazolidina.
ES2141744T3 (es) Azaquinoxalinas, procedimiento para su preparacion y su empleo.
ES2128307T3 (es) Derivados de 1,4,7,10-tetraaza-ciclododecano monosustituidos en n, procedimiento para su preparacion y agentes farmaceuticos que los contienen.
ATE195737T1 (de) Antagonisten des fibrinogenrezeptors
ES2093286T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE59008844D1 (de) Benzylselenobenzamide von Aminopyridinen und Picolylaminen.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
ES2052133T3 (es) Picolilselenio-benzamidas de aminopiridinas, anilinas y picolilaminas.
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 552765

Country of ref document: ES